Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LAPTM4B - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LAMTOR5 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
EMC4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
KLHDC2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
TMEM55A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARF4 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
UBQLN1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RPA3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARL1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
MTM1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
DNAJB9 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
HEBP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RAB18 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PHYHIPL - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
INTU - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RPE - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
VPS37A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
METAP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GPN3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on